TYR and melanoma: With respect to the role of tyrosinase palmitoylation in melanogenesis, 2-BP (25 μM, 48 h) treatment in HM3KO human melanoma cells reduced its palmitoylation level but increased protein levels (implicating elevated protein stability), as determined by the acyl-RAC and 17-ODYA methods [97].